The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The federal government’s newly announced savings on 15 expensive prescriptions include the popular Ozempic family of ...

Medicare has negotiated list price reductions of up to 85% for 15 widely used drugs in the program, including Novo Nordisk's ...

The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

The Centers for Medicare and Medicaid Services announced that prices for 15 prescription drugs, including Ozempic, would be ...

Government health officials announced on Tuesday that Medicare recipients will soon pay less for 15 prescription drugs, ...